0000899243-22-004878.txt : 20220204
0000899243-22-004878.hdr.sgml : 20220204
20220204180932
ACCESSION NUMBER: 0000899243-22-004878
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220202
FILED AS OF DATE: 20220204
DATE AS OF CHANGE: 20220204
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Tessier Maude
CENTRAL INDEX KEY: 0001848534
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40287
FILM NUMBER: 22594965
MAIL ADDRESS:
STREET 1: C/O IKENA ONCOLOGY, INC.
STREET 2: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Ikena Oncology, Inc.
CENTRAL INDEX KEY: 0001835579
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 50 NORTHERN AVE.
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 857-343-8292
MAIL ADDRESS:
STREET 1: 50 NORTHERN AVE.
CITY: BOSTON
STATE: MA
ZIP: 02210
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-02-02
0
0001835579
Ikena Oncology, Inc.
IKNA
0001848534
Tessier Maude
C/O IKENA ONCOLOGY, INC.
645 SUMMER STREET, SUITE 101
BOSTON
MA
02210
0
1
0
0
Chief Business Officer
Stock Option (Right to Buy)
11.45
2022-02-02
4
A
0
40000
0.00
A
2032-02-02
Common Stock
40000
40000
D
25% of the shares subject to this option shall vest and become exercisable on January 1, 2023, with the remainder vesting in 36 substantially equal monthly installments thereafter.
/s/ Douglas R. Carlson, as Attorney-in-Fact for Maude Tessier
2022-02-04